Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion

Archives of Neurology

Volumn 60, Issue 10, 2003, Pages 1421-1425

  Krasnianski, Michael ^a   Eger, Katharina ^a   Neudecker, Stephan ^a   Jakubiczka, Sibylle ^b   Zierz, Stephan ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 4Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; EXTERNAL OPHTHALMOPLEGIA; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 4; FACE; FEMALE; GENE DELETION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; OPHTHALMOPLEGIA; PHENOTYPE;

EID: 0141924432     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.10.1421     Document Type: Article

References (15)

1. Lunt PW, Harper PS. Genetic counselling in facioscapulohumeral muscular dystrophy. J Med Genet. 1991;28:655-664.
2. Landouzy L, Dejerine J. De la myopathie atrophique progressive (myopatie hereditaire debutant, dans l'enfance, par la face sans alteration du systeme nerveux). C R Acad Sci (Paris). 1884;98:53-55.
3. Padberg GW, Lunt PW, Koch M, Fardeau M. Facioscapulohumeral muscular dystrophy. In: Emery AEH, ed. Diagnostic Criteria for Neuromuscular Disorders. 2nd ed. London, England: Royal Society of Medicine Press; 1997:9-16.
4. Upadhyaya M, Maynard J, Rogers MT, et al. Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD. J Med Genet. 1997;34:476-479.
5. Griggs RC, Tawil R, Storvick D, Mendell JR, Altherr MR. Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases. Neurology. 1993; 43:2369-2372.
6. Felice KJ, North WA, Moore SA, Matthews KD. FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy. Neurology. 2000;54:1927-1931.
7. Felice KJ, Moore SA. Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle Nerve. 2001;24:352-356.
8. van der Kooi AJ, Visser MC, Rosenber N, et al. Extension of the clinical range of facioscapular muscular dystrophy: report of six cases. J Neurol Neurosurg Psychiatry. 2000;69:114-116.
9. van der Maarel SM, Deidda G, Lemmers RJ, et al. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD). J Med Genet. 1999;36:823-828.
10. Jardine PE, Upadhyaya J, Maynard P, Harper P, Lunt PW. Ascapular onset muscular dystrophy without facial involvement: possible allelism with facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 1994;4:477-482.
11. Padberg G. Facioscapulohumeral Disease [doctor of medicine thesis]. Leiden, the Netherlands: University of Leiden; 1982:23-24.
12. Bushby KMD, Pollitt C, Johnson MA, Rogers MT, Chinnery PF. Muscle pain as a prominent feature of facioscapular muscular dystrophy (FSHD): four illustrative case reports. Neuromuscul Disord. 1998;8:574-579.
13. Jones KJ, North KN. External ophthalmoplegia in neuromuscular disorders: case report and review of the literature. Neuromuscul Disord. 1997;7:143-151.
14. Laforet P, Lombes A, Eymard B, et al. Chronic progressive external ophthalmoplegia with ragged-red fibers: clinical, morphological and genetic investigations in 43 patients. Neuromuscul Disord. 1995;5:399-413.
15. Lemmers RJ, de Kievit P, Sandkuijl L, et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of two variants of the 4q subtelomere. Nat Genet. 2002;32:235-236.